Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARENT Trial: Entresto for Pulmonary Artery Pressure Reduction in HFrEF
NCT02788656Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure with reduced ejection fraction (HFrEF), sponsored by Brigham and Women's Hospital. Started Sep 2016; status: terminated.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT02788656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02788656.